Novel Therapies for Neovascular Retinal Disease - Expert Analysis of New Key Data

In this PER On Air Ophthalmology Times Podcast, a panel of experts takes a closer look at newer-generation anti-VEGF agents for the treatment of nAMD and DME, sharing insights into clinical trial and real-world data, patient education, and other important considerations for treatment.

Faculty:

Roger A. Goldberg, MD, MBA
Vitreoretinal Specialist
Bay Area Retina Associates
Volunteer Faculty
California Pacific Medical Center
Walnut Creek, CA

David R.P. Almeida, MD, PhD, MBA
President and CEO
Erie Retina Research
Center for Advanced Surgical Exploration
Erie, PA

Jennifer I. Lim, MD, FARVO
Marion H. Schenk Esq. Chair in Ophthalmology for Research of the Aging Eye
UIC Distinguished Professor of Ophthalmology
Director, Retina Service
Vice-Chair, Diversity and Inclusion
University of Illinois at Chicago
Chicago, IL